Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Common Equity (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 15 years of Common Equity data on record, last reported at $1.8 billion in Q3 2025.

  • For Q3 2025, Common Equity rose 5.38% year-over-year to $1.8 billion; the TTM value through Sep 2025 reached $1.8 billion, up 5.38%, while the annual FY2025 figure was $1.8 billion, 10.86% up from the prior year.
  • Common Equity reached $1.8 billion in Q3 2025 per PBH's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.9 billion in Q2 2025 and bottomed at $1.4 billion in Q1 2021.
  • Average Common Equity over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
  • Peak YoY movement for Common Equity: rose 16.15% in 2022, then decreased 8.27% in 2023.
  • A 5-year view of Common Equity shows it stood at $1.5 billion in 2021, then rose by 11.1% to $1.7 billion in 2022, then dropped by 5.12% to $1.6 billion in 2023, then increased by 11.74% to $1.8 billion in 2024, then rose by 2.04% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $1.8 billion in Q3 2025, $1.9 billion in Q2 2025, and $1.8 billion in Q1 2025.